Rockefeller researchers reveal the mechanisms behind malignant turn of events in cancer

FHS
July 31, 2023
11:44 pm

Early on, every stem cell faces a fateful choice. During skin development, for instance, the embryonic epidermis begins as a single layer of epidermal progenitor cells.

Confido Health Raises $3M to Automate Healthcare Ops with AI Digital Workers

What You Should Know: – Confido Health, a healthcare technology company developing AI-powered digital workers for specialty practices, has secured $3M in seed funding led

December 19, 2024

Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and

January 21, 2025

AstraZeneca and Daiichi score another win with Enhertu’s EU approval in lung cancer – Pharmaceutical Technology

Sales for Enhertu are forecasted to exceed $10.65bn by 2029. Credit: Ivan-balvan via Getty Images. The European Commission (EC) has approved Daiichi Sankyo and AstraZeneca’s

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.